No Data
No Data
Finch Therapeutics Gr Q4 EPS $(1.89) Up From $(16.80) YoY
Finch Therapeutics Gr (NASDAQ:FNCH) reported quarterly losses of $(1.89) per share. This is a 88.75 percent increase over losses of $(16.80) per share from the same period last year.
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersRegulus Therapeutics (NASDAQ:RGLS) stock moved upwards by 84.8% to $2.55 during Tuesday's pre-market session. The company's market cap stands at $51.5 million. Assure Hldgs (NASDAQ:IONM) stock
Finch Therapeutics Faces Nasdaq Delisting and Patent Litigation
AMKR, ALKS and CLFD Are Among After Hour Movers
Redhill Biopharma, Ampio Pharmaceuticals Among Healthcare Movers
Finch Therapeutics(FNCH.US) Director Sells US$5,350.8 in Common Stocks
$Finch Therapeutics(FNCH.US)$ Director SMISEK JEFFERY A sold 1,470 shares of Common Stocks on Nov 22, 2023 at an average price of $3.64 for a total value of $5,350.8.Source: Announcement What is state
No Data